Addex Therapeutics Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CHF 1.61 million compared to CHF 1.42 million a year ago. Net loss was CHF 10.56 million compared to CHF 20.8 million a year ago.

Basic loss per share from continuing operations was CHF 0.14 compared to CHF 0.46 a year ago.